HCA Healthcare (HCA) Stock Forecast, Price Target & Predictions
HCA Stock Forecast
HCA Healthcare stock forecast is as follows: an average price target of $310.75 (represents a -6.68% downside from HCA’s last price of $333.00) and a rating consensus of 'Buy', based on 24 wall street analysts offering a 1-year stock forecast.
HCA Price Target
The average price target for HCA Healthcare (HCA) is $310.75 based on 1-year price targets from 24 Wall Street analysts in the past 3 months, with a price target range of $441.00 to $224.00. This represents a potential -6.68% downside from HCA's last price of $333.00.
HCA Analyst Ratings
According to 24 Wall Street analysts, HCA Healthcare's rating consensus is 'Buy'. The analyst rating breakdown for HCA stock is 0 'Strong Buy' (0.00%), 18 'Buy' (75.00%), 6 'Hold' (25.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
HCA Healthcare Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Oct 28, 2024 | Michael Wiederhorn | Oppenheimer | $400.00 | $359.07 | 11.40% | 20.12% |
| Oct 28, 2024 | Matthew Gillmor | KeyBanc | $420.00 | $359.07 | 16.97% | 26.13% |
| Oct 28, 2024 | Ann Hynes | Mizuho Securities | $425.00 | $359.16 | 18.33% | 27.63% |
| Oct 10, 2024 | Matthew Gillmor | KeyBanc | $475.00 | $387.25 | 22.66% | 42.64% |
| Oct 01, 2024 | Pito Chickering | Deutsche Bank | $441.00 | $406.01 | 8.62% | 32.43% |
| Aug 19, 2024 | David MacDonald | Truist Financial | $430.00 | $373.77 | 15.04% | 29.13% |
| Jun 28, 2024 | Pito Chickering | Deutsche Bank | $375.00 | $335.04 | 11.93% | 12.61% |
| Jun 06, 2024 | Brian Tanquilut | Jefferies | $390.00 | $336.82 | 15.79% | 17.12% |
| Apr 29, 2024 | Ben Hendrix | RBC Capital | $329.00 | $311.07 | 5.76% | -1.20% |
| Apr 29, 2024 | Michael Wiederhorn | Oppenheimer | $345.00 | $306.69 | 12.49% | 3.60% |
The latest HCA Healthcare stock forecast, released on Oct 28, 2024 by Michael Wiederhorn from Oppenheimer, set a price target of $400.00, which represents a 11.40% increase from the stock price at the time of the forecast ($359.07), and a 20.12% increase from HCA last price ($333.00).
HCA Healthcare Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 3 | 5 | 11 |
| Avg Price Target | $415.00 | $432.20 | $399.00 |
| Last Closing Price | $333.00 | $333.00 | $333.00 |
| Upside/Downside | 24.62% | 29.79% | 19.82% |
In the current month, the average price target of HCA Healthcare stock is $415.00, according to 3 Wall Street analysts offering twelve months forecast. The average price target represents a 24.62% increase as opposed to HCA Healthcare's last price of $333.00. This month's average price target is down -3.98% compared to last quarter, and up 4.01% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Oct 28, 2024 | Oppenheimer | Outperform | Outperform | Hold |
| Oct 28, 2024 | KeyBanc | Overweight | Overweight | Hold |
| Oct 16, 2024 | Cowen & Co. | Buy | Buy | Hold |
| Oct 10, 2024 | KeyBanc | - | Overweight | Initialise |
| Oct 01, 2024 | Deutsche Bank | Buy | Buy | Hold |
| Sep 03, 2024 | Morgan Stanley | - | Equal-Weight | Initialise |
| Aug 23, 2024 | RBC Capital | Outperform | Outperform | Hold |
| Jul 30, 2024 | Wells Fargo | Equal-Weight | Equal-Weight | Hold |
| Jul 25, 2024 | Cantor Fitzgerald | Overweight | Overweight | Hold |
| Jul 24, 2024 | RBC Capital | Outperform | Outperform | Hold |
HCA Healthcare's last stock rating was published by Oppenheimer on Oct 28, 2024. The company gave HCA a "Outperform" rating, the same as its previous rate.
HCA Healthcare Financial Forecast
HCA Healthcare Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $16.21B | $15.86B | $15.59B | $15.50B | $14.97B | $14.82B | $14.95B | $15.06B | $15.28B | $14.44B | $13.98B | $14.29B | $13.31B | $11.07B | $12.86B | $13.52B | $12.69B |
| Avg Forecast | $20.50B | $19.44B | $19.45B | $19.26B | $19.35B | $18.50B | $18.49B | $18.28B | $18.30B | $17.54B | $17.05B | $16.81B | $16.51B | $15.82B | $15.63B | $15.27B | $15.63B | $15.00B | $14.72B | $14.75B | $15.35B | $14.53B | $13.61B | $13.63B | $13.99B | $12.85B | $10.09B | $13.06B | $13.36B | $12.50B |
| High Forecast | $20.91B | $19.83B | $19.84B | $19.65B | $19.73B | $18.86B | $18.86B | $18.41B | $18.81B | $17.57B | $17.05B | $16.81B | $16.78B | $15.96B | $15.94B | $15.57B | $15.94B | $15.00B | $14.72B | $14.75B | $15.35B | $14.53B | $13.61B | $13.63B | $13.99B | $12.85B | $10.09B | $13.06B | $13.36B | $12.50B |
| Low Forecast | $20.18B | $19.14B | $19.15B | $18.97B | $19.05B | $18.21B | $18.20B | $18.06B | $18.03B | $17.51B | $17.05B | $16.81B | $16.32B | $15.39B | $15.39B | $15.03B | $15.39B | $15.00B | $14.72B | $14.75B | $15.35B | $14.53B | $13.61B | $13.63B | $13.99B | $12.85B | $10.09B | $13.06B | $13.36B | $12.50B |
| # Analysts | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 10 | 14 | 9 | 7 | 4 | 9 | 18 | 15 | 9 | 10 | 16 | 8 | 10 | 9 | 9 | 13 | 9 | 9 | 9 | 9 | 9 | 8 | 8 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.02% | 1.01% | 1.02% | 0.99% | 1.00% | 1.01% | 1.01% | 0.98% | 1.05% | 1.06% | 1.03% | 1.02% | 1.04% | 1.10% | 0.98% | 1.01% | 1.02% |
HCA Healthcare's average Quarter revenue forecast for Dec 23 based on 9 analysts is $16.51B, with a low forecast of $16.32B, and a high forecast of $16.78B. HCA's average Quarter revenue forecast represents a 1.85% increase compared to the company's last Quarter revenue of $16.21B (Sep 23).
HCA Healthcare EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 10 | 14 | 9 | 7 | 4 | 9 | 18 | 15 | 9 | 10 | 16 | 8 | 10 | 9 | 9 | 13 | 9 | 9 | 9 | 9 | 9 | 8 | 8 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $2.88B | $3.06B | $3.17B | $3.18B | $2.90B | $3.04B | $2.94B | $3.52B | $4.07B | $3.00B | $2.90B | $2.85B | $1.96B | $2.50B | $1.79B | $2.54B | $1.92B |
| Avg Forecast | $4.25B | $4.03B | $4.03B | $3.99B | $4.01B | $3.83B | $3.83B | $3.79B | $3.79B | $3.63B | $3.53B | $3.44B | $3.42B | $3.28B | $3.24B | $3.13B | $3.97B | $2.99B | $2.94B | $2.85B | $3.06B | $2.90B | $2.72B | $2.19B | $2.79B | $2.56B | $2.01B | $2.01B | $2.67B | $2.50B |
| High Forecast | $4.33B | $4.11B | $4.11B | $4.07B | $4.09B | $3.91B | $3.91B | $3.81B | $3.90B | $3.64B | $3.53B | $4.13B | $3.48B | $3.31B | $3.30B | $3.76B | $4.76B | $2.99B | $2.94B | $3.42B | $3.06B | $2.90B | $2.72B | $2.63B | $2.79B | $2.56B | $2.01B | $2.41B | $2.67B | $2.50B |
| Low Forecast | $4.18B | $3.97B | $3.97B | $3.93B | $3.95B | $3.77B | $3.77B | $3.74B | $3.74B | $3.63B | $3.53B | $2.76B | $3.38B | $3.19B | $3.19B | $2.50B | $3.17B | $2.99B | $2.94B | $2.28B | $3.06B | $2.90B | $2.72B | $1.75B | $2.79B | $2.56B | $2.01B | $1.60B | $2.67B | $2.50B |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.88% | 0.94% | 1.01% | 0.80% | 0.97% | 1.03% | 1.03% | 1.15% | 1.40% | 1.10% | 1.32% | 1.02% | 0.76% | 1.24% | 0.89% | 0.95% | 0.77% |
9 analysts predict HCA's average Quarter EBITDA for Dec 23 to be $3.42B, with a high of $3.48B and a low of $3.38B. This is 18.82% upper than HCA Healthcare's previous annual EBITDA (Sep 23) of $2.88B.
HCA Healthcare Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 10 | 14 | 9 | 7 | 4 | 9 | 18 | 15 | 9 | 10 | 16 | 8 | 10 | 9 | 9 | 13 | 9 | 9 | 9 | 9 | 9 | 8 | 8 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.08B | $1.19B | $1.36B | $2.08B | $1.13B | $1.16B | $1.27B | $2.00B | $2.27B | $1.45B | $1.42B | $1.43B | $668.00M | $1.08B | $581.00M | $1.07B | $612.00M |
| Avg Forecast | $2.00B | $1.54B | $1.74B | $1.66B | $1.83B | $1.44B | $1.62B | $1.51B | $1.61B | $1.29B | $1.28B | $1.59B | $1.31B | $1.03B | $1.10B | $1.44B | $2.04B | $1.02B | $976.94M | $1.31B | $1.19B | $1.07B | $835.19M | $1.08B | $942.06M | $605.78M | $-51.35M | $649.22M | $816.57M | $561.89M |
| High Forecast | $2.06B | $1.58B | $1.78B | $1.70B | $1.87B | $1.47B | $1.66B | $1.56B | $1.75B | $1.30B | $1.28B | $1.90B | $1.40B | $1.12B | $1.13B | $1.73B | $2.45B | $1.02B | $976.94M | $1.57B | $1.19B | $1.07B | $835.19M | $1.29B | $942.06M | $605.78M | $-51.35M | $779.07M | $816.57M | $561.89M |
| Low Forecast | $1.96B | $1.51B | $1.70B | $1.63B | $1.79B | $1.41B | $1.58B | $1.44B | $1.53B | $1.28B | $1.28B | $1.27B | $1.28B | $963.33M | $1.08B | $1.15B | $1.64B | $1.02B | $976.94M | $1.05B | $1.19B | $1.07B | $835.19M | $861.49M | $942.06M | $605.78M | $-51.35M | $519.38M | $816.57M | $561.89M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.04% | 1.08% | 0.94% | 1.02% | 1.11% | 1.18% | 0.97% | 1.68% | 2.12% | 1.74% | 1.32% | 1.51% | 1.10% | -21.01% | 0.89% | 1.31% | 1.09% |
HCA Healthcare's average Quarter net income forecast for Dec 23 is $1.31B, with a range of $1.28B to $1.40B. HCA's average Quarter net income forecast represents a 21.59% increase compared to the company's last Quarter net income of $1.08B (Sep 23).
HCA Healthcare SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 10 | 14 | 9 | 7 | 4 | 9 | 18 | 15 | 9 | 10 | 16 | 8 | 10 | 9 | 9 | 13 | 9 | 9 | 9 | 9 | 9 | 8 | 8 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $7.56B | $7.28B | $7.08B | $7.05B | $6.90B | $6.79B | $6.94B | $7.00B | $7.09B | $6.38B | $6.30B | $6.33B | $6.10B | $5.33B | $6.12B | $6.11B | $5.97B |
| Avg Forecast | $9.39B | $8.91B | $8.91B | $8.83B | $8.87B | $8.48B | $8.47B | $8.38B | $8.39B | $8.04B | $7.82B | $8.65B | $7.57B | $7.25B | $7.16B | $7.87B | $7.89B | $6.87B | $6.75B | $7.15B | $7.04B | $6.66B | $6.24B | $4.77B | $6.41B | $5.89B | $4.62B | $6.84B | $6.12B | $5.73B |
| High Forecast | $9.58B | $9.09B | $9.09B | $9.00B | $9.04B | $8.65B | $8.64B | $8.44B | $8.62B | $8.05B | $7.82B | $10.38B | $7.69B | $7.31B | $7.31B | $9.44B | $9.46B | $6.87B | $6.75B | $8.58B | $7.04B | $6.66B | $6.24B | $5.72B | $6.41B | $5.89B | $4.62B | $8.20B | $6.12B | $5.73B |
| Low Forecast | $9.25B | $8.77B | $8.78B | $8.69B | $8.73B | $8.34B | $8.34B | $8.27B | $8.26B | $8.02B | $7.82B | $6.92B | $7.48B | $7.05B | $7.05B | $6.29B | $6.31B | $6.87B | $6.75B | $5.72B | $7.04B | $6.66B | $6.24B | $3.81B | $6.41B | $5.89B | $4.62B | $5.47B | $6.12B | $5.73B |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.04% | 1.02% | 0.90% | 0.89% | 1.00% | 1.01% | 0.97% | 0.99% | 1.06% | 1.02% | 1.32% | 0.99% | 1.04% | 1.15% | 0.89% | 1.00% | 1.04% |
HCA Healthcare's average Quarter SG&A projection for Dec 23 is $7.57B, based on 9 Wall Street analysts, with a range of $7.48B to $7.69B. The forecast indicates a 0.16% rise compared to HCA last annual SG&A of $7.56B (Sep 23).
HCA Healthcare EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 10 | 14 | 9 | 7 | 4 | 9 | 18 | 15 | 9 | 10 | 16 | 8 | 10 | 9 | 9 | 13 | 9 | 9 | 9 | 9 | 9 | 8 | 8 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $3.97 | $4.34 | $4.92 | $7.50 | $3.99 | $4.02 | $4.26 | $6.56 | $7.24 | $4.49 | $4.26 | $4.20 | $1.97 | $3.19 | $1.72 | $3.16 | $1.80 |
| Avg Forecast | $7.71 | $5.93 | $6.69 | $6.39 | $7.03 | $5.53 | $6.22 | $5.82 | $6.18 | $4.96 | $4.93 | $5.06 | $5.05 | $3.98 | $4.25 | $3.91 | $4.79 | $3.88 | $3.70 | $4.26 | $4.52 | $4.06 | $3.16 | $3.32 | $3.57 | $2.29 | $-0.19 | $2.64 | $3.09 | $2.13 |
| High Forecast | $7.91 | $6.09 | $6.86 | $6.55 | $7.21 | $5.67 | $6.38 | $6.01 | $6.72 | $5.00 | $4.93 | $5.06 | $5.37 | $4.30 | $4.36 | $4.01 | $4.91 | $3.88 | $3.70 | $4.26 | $4.52 | $4.06 | $3.16 | $3.32 | $3.57 | $2.29 | $-0.19 | $2.64 | $3.09 | $2.13 |
| Low Forecast | $7.56 | $5.81 | $6.56 | $6.26 | $6.89 | $5.42 | $6.09 | $5.54 | $5.88 | $4.92 | $4.93 | $5.06 | $4.91 | $3.71 | $4.16 | $3.83 | $4.69 | $3.88 | $3.70 | $4.26 | $4.52 | $4.06 | $3.16 | $3.32 | $3.57 | $2.29 | $-0.19 | $2.64 | $3.09 | $2.13 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.00% | 1.02% | 1.26% | 1.57% | 1.03% | 1.09% | 1.00% | 1.45% | 1.78% | 1.42% | 1.28% | 1.18% | 0.86% | -16.42% | 0.65% | 1.02% | 0.85% |
According to 9 Wall Street analysts, HCA Healthcare's projected average Quarter EPS for Dec 23 is $5.05, with a low estimate of $4.91 and a high estimate of $5.37. This represents a 27.14% increase compared to HCA previous annual EPS of $3.97 (Sep 23).
HCA Healthcare Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| CYH | Community Health Systems | $3.83 | $11.00 | 187.21% | Buy |
| ACHC | Acadia Healthcare Company | $39.10 | $82.33 | 110.56% | Buy |
| CCRN | Cross Country Healthcare | $10.21 | $21.00 | 105.68% | Buy |
| SGRY | Surgery Partners | $22.51 | $40.80 | 81.25% | Buy |
| AMED | Amedisys | $90.00 | $143.38 | 59.31% | Hold |
| ADUS | Addus HomeCare | $120.99 | $132.80 | 9.76% | Buy |
| UHS | Universal Health Services | $197.52 | $208.47 | 5.54% | Hold |
| ENSG | Ensign Group | $144.66 | $148.20 | 2.45% | Buy |
| EHC | Encompass Health | $98.93 | $97.00 | -1.95% | Buy |
| HCA | HCA Healthcare | $333.00 | $310.75 | -6.68% | Buy |
| THC | Tenet Healthcare | $151.84 | $128.60 | -15.31% | Buy |
| FMS | Fresenius Medical Care AG & Co. KGaA | $21.79 | $17.85 | -18.08% | Hold |
| DVA | DaVita | $161.40 | $125.50 | -22.24% | Hold |